NCT07445399 (DRAW) is a NA clinical trial of warm color in Anesthesia, sponsored by Zhihong LU.

Who is sponsoring NCT07445399?

NCT07445399 is sponsored by Zhihong LU.

What drugs are being tested in NCT07445399?

Interventions in NCT07445399: warm color, cold color, sharp shape, smooth shape.

What condition does NCT07445399 study?

NCT07445399 studies Anesthesia, Anxiety.

Is NCT07445399 still recruiting?

NCT07445399 is currently not yet recruiting. Last updated 3 March 2026.

Last reviewed 2026-03-03 · How we verify

NCT07445399: DRAW

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Drawing Therapy for pReoperative Anxiety in Waiting (DRAW)

Not yet recruiting NA Last updated 3 March 2026

What this trial tests

NA trial testing warm color in Anesthesia in 175 participants. Not yet recruiting.

Timeline

30 March 2026

Primary endpoint
30 September 2026

30 September 2026

Quick facts

Lead sponsor	Zhihong LU
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	175
Start date	30 March 2026
Primary completion	30 September 2026
Estimated completion	30 September 2026

Drugs / interventions tested

warm color
cold color
sharp shape
smooth shape

Conditions studied

Anesthesia — all drugs for Anesthesia →
Anxiety — all drugs for Anxiety →

Sponsor

Zhihong LU — full company profile →

Who can join

18 and older, any sex, with Anesthesia or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will use a factorial design to compare the effects of different colors and shapes on patients' preoperative anxiety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting

Other Zhihong LU trials

Trials by the same sponsor.

NCT07440121 — Optimized Strict Fluid Management Helps Improve Endpoints After Liver Dissection · NA · not yet recruiting
NCT07433218 — Frequency of Electrical Acupoint Stimulation on Hypotension During Induction · NA · not yet recruiting
NCT06521632 — Acupoint Stimulation Improves Cognition Under Hypoxia · NA · not yet recruiting
NCT06161662 — STimulation Electronically of Acupoints for Postoperative Delirium in elderlY Patients · NA · completed
NCT06170918 — Dose of Remimazolam in Children for Intubation · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07445399 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhihong LU
Last refreshed: 3 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07445399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing